Adenosine-to-inosine RNA editing mediated by adars in esophageal squamous cell carcinoma

Cancer Research

Volumn 74, Issue 3, 2014, Pages 840-851

  Qin, Yan Ru ^a   Qiao, Jun Jing ^a,f   Chan, Tim Hon Man ^f   Zhu, Ying Hui ^b   Li, Fang Fang ^d   Liu, Haibo ^c   Fei, Jing ^f   Li, Yan ^b   Guan, Xin Yuan ^b,e   Chen, Leilei ^f  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d Nanyang City First People's Hospital   (China)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE, TUMOR; COHORT STUDIES; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INOSINE; ONCOGENE PROTEINS; RNA EDITING;

EID: 84893833808     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2545     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002.CA Cancer J Clin 2005;55:74-108.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50.
3. Valente L, Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 2005;79:299-338.
4. Athanasiadis A, Rich A, Maas S. Widespread A-to-I RNA editing of Alucontaining mRNAs in the human transcriptome. PLoS Biol 2004;2: e391.
5. Blow M, Futreal PA, Wooster R, Stratton MR. Asurvey ofRNAediting in human brain. Genome Res 2004;14:2379-87.
6. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, et al. Genomewide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009;324:1210-3.
7. Maas S, Kawahara Y, Tamburro KM, Nishikura K. A-to-I RNA editing and human disease. RNA Biol 2006;3:1-9.
8. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2010;79:321-49.
9. Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995;15:5376-88.
10. Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 2013;19:209-16.
11. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-84.
12. Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut 2013 Jun [Epub ahead of print]
13. Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 2001;61:3806-9.
14. Bass BL.RNAediting by adenosine deaminases that act on RNA. Annu Rev Biochem 2002;71:817-46.
15. Wang LD, Qin YR, Fan ZM, Kwong D, Guan XY, Tsao GS, et al. Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China. Dis Esophagus 2006;19:459-67.
16. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997;387:303-8.
17. Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 1993; 75:1361-70.
18. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 2007;17:1586-95.
19. Bass BL, Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988;55:1089-98.
20. O'Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, Jenny A, et al. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol 1995;15: 1389-97.
21. Paupard MC, O'Connell MA, Gerber AP, Zukin RS. Patterns of developmental expression of the RNA editing enzyme rADAR2. Neuroscience 2000;95:869-79.
22. Sansam CL, Wells KS, Emeson RB. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci U S A 2003;100:14018-23.
23. Farajollahi S, Maas S. Molecular diversity through RNA editing: a balancing act. Trends Genet 2010;26:221-30.
24. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-809.
25. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009;461:809-13.
26. DeCerbo J, Carmichael GG. Retention and repression: fates of hyperedited RNAs in the nucleus. Curr Opin Cell Biol 2005;17:302-8.
27. Gu T, Buaas FW, Simons AK, Ackert-Bicknell CL, Braun RE, Hibbs MA. Canonical A-to-I and C-to-U RNA editing is enriched at 30UTRs and microRNA target sites in multiple mouse tissues. PloS ONE 2012;7: e33720.
28. Prasanth KV, Prasanth SG, Xuan Z, Hearn S, Freier SM, Bennett CF, et al. Regulating gene expression through RNA nuclear retention. Cell 2005;123:249-63.
29. Zhang Z, Carmichael GG. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001;106:465-75.
30. Murakami Y, Ichiba T, Matsufuji S, Hayashi S. Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase. J Biol Chem 1996;271:3340-2.
31. Nilsson J, Grahn B, Heby O. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem J 2000;346 Pt 3:699-704.
32. Choi KS, Suh YH, Kim WH, Lee TH, Jung MH. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity. Biochem Biophys Res Commun 2005;328:206-12.
33. Keren-Paz A, Bercovich Z, Porat Z, Erez O, Brener O, Kahana C. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions. Oncogene 2006;25:5163-72.
34. Li Y, Chen L, Chan TH, Guan XY. Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing. Int J Biochem Cell Biol 2013;45:1843-8.